SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001683168-23-007111
Filing Date
2023-10-12
Accepted
2023-10-12 18:01:19
Documents
1
Period of Report
2023-09-21

Document Format Files

Seq Description Document Type Size
1 ownership.html 4/A  
1 ownership.xml 4/A 4518
  Complete submission text file 0001683168-23-007111.txt   5898
Mailing Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027
Business Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027 1-800-946-9185
CNS Pharmaceuticals, Inc. (Issuer) CIK: 0001729427 (see all company filings)

IRS No.: 822318545 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CNS PHARMACEUTICALS, INC. 2100 WEST LOOP SOUTH STE 900 HOUSTON TX 77027
Business Address
Gumulka Jerzy (Reporting) CIK: 0001793252 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-39126 | Film No.: 231323510